XCL1 and renal carcinoma: Interestingly, the Human Protein Atlas data also provided evidence of XCL1-overexpressing tumour cells in a number of cancer types, and this overexpression is significantly correlated with a shorter overall survival rate in patients with colorectal and renal cancer (Supplementary Fig. 15c).